Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials: A Meta-analysis

Overview of attention for article published in JAMA Oncology, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 4 news outlets
twitter: 76 X users
facebook: 1 Facebook page

googleplus: 1 Google+ user
reddit: 1 Redditor

Readers on

mendeley: 103 Mendeley

So far, Altmetric has seen 94 X posts from 76 X users, with an upper bound of 229,728 followers.

RT @JAMAOnc: https://t.co/a2mvnS2Er5

https://t.co/a2mvnS2Er5

RT @JAMAOnc: https://t.co/4PBFfewCiF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 90 additional X posts.